In the general device market would it be better for a company seeking FDA clearance to have all other legal issues resolved before the FDA decision, and if so is it possible the FDA have been asked not to publish a decision until that time?
In a similar vein could aforementioned company secure new licencing deals on the back of the held up FDA clearance?
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.